Phase 2 Chronic Inflammatory Demyelinating Polyneuropathy Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 2
IMVT-1402 in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Chronic Inflammatory Demyelinating Polyneuropathy
Immunovant Sciences GmbH162 enrolled135 locationsNCT07032662
Recruiting
Phase 2
Safety, Tolerability, and Efficacy of NVG-2089 in Participants With CIDP
Chronic Inflammatory Demyelinating Polyneuropathy
Nuvig Therapeutics, Inc.60 enrolled1 locationNCT07027111
Not Yet Recruiting
Phase 2
A Phase 2, Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous NVG-2089 in Participants with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Chronic Inflammatory Demyelinating Polyneuropathy
Nuvig Therapeutics60 enrolled9 locationsACTRN12625000534482